IQVIA

ASH 2017: CAR-T therapy and beyond

https://pharmaphorum.com/views-analysis-oncology/ash-2017-car-t-therapy-beyond/

When science and biology combine – the outlook for ADCs in cancer drug development

https://pharmaphorum.com/partner-content-oncology/science-biology-combine-outlook-adcs-cancer-drug-development/

Top 5 challenges of immuno-oncology clinical trials

https://pharmaphorum.com/partner-content-oncology/top-5-challenges-of-immunooncology-clinical-trials/

Oncology – the current landscape and what it means for the future

https://pharmaphorum.com/partner-content-oncology/oncology-current-landscape-means-future/

What oncologists need from you when launching a new therapy

https://pharmaphorum.com/partner-content/oncologists-need-launching-new-therapy/

How RACE legislation is changing the face of pediatric oncology in the US

https://pharmaphorum.com/partner-content-oncology/race-legislation-changing-face-pediatric-oncology-us/

11/23/2017

The evolution of pharma social media intelligence

https://pharmaphorum.com/debates-insight-sales-marketing/evolution-pharma-social-media-intelligence/

Biosimilars in oncology: a €2billion opportunity for European healthcare

https://pharmaphorum.com/views-and-analysis/biosimilars-oncology-european-healthcare/

1 2 3

Close in 10 seconds

Pharmaphorum.com

Search